Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe. Off-label use is when a company offers and […]
The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings. A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising.” Why […]
U.S. health officials are now finally taking an assertive position regarding women getting breast implants by stating that stronger warnings and more details about the possible risks and complications including links to cancer. Why has there been a multi-year FDA delay on this in the USA?
Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS) Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses. They also […]